ZFIN Image: Lai et al., 2023, Fig. 10

Image

Figure Caption

Fig. 10 Activation of the MEK/ERK signaling pathway is the underlying mechanism of XAT. Meg-01 cells were treated with XAT (20 μM), XAT (20 μM) + SCH772984 (0.75 μM), or SCH772984 (0.75 μM) for 4 days. (A) Representative images of each group under a microscope. (B, C) FCM analysis of the expression of CD41 and CD42b. The histogram shows the percentage of CD41 + /CD42b+ cells for each group. F _(3,8) = 292.2; *P < .05, ^**P < .01, ^***P < .001, vs XAT; n = 3^{. ###}P < .001, vs control; n = 3. (D) The expression of p-MEK (left) and p-ERK (right) was detected by WB. F _(3,8) = 3.047 (left); F _(3,8) = 15.36 (right); *P < .05, ^**P < .01, ^***P < .001, vs XAT; n = 3. ^#P < .05, vs control^; n = 3.

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomed. Pharmacother.